Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skymap Pharmaceuticals operates as a large-scale manufacturer with EU GMP-approved facilities and over 500 commercialized formulations addressing anti-infective, cardiovascular, metabolic, ophthalmic, and other therapeutic areas, marketed globally with a major focus on generic drugs.[1][2][4][5][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Skymap Pharmaceuticals.